KEYNOTE-001

July 5, 2016July 5, 2016

Lung Cancer Therapy Keytruda, Already OK’d for Different Cancers, Recommended for Approval in EU

Lung Cancer, News

Merck recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of the drug Keytruda (pembrolizumab), to be used ... Read more

June 4, 2015June 4, 2015

FDA Accepts Supplemental Biologics License Application For KEYTRUDA

Lung Cancer, News

Merck recently announced that the U.S. Food and Drug Administration (FDA) has agreed to review a supplemental Biologics License Application (sBLA) for the company’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab), with the ... Read more